RAC 2.20% $1.78 race oncology ltd

Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-22

  1. 1,614 Posts.
    lightbulb Created with Sketch. 631
    I might be completely off base but from my understanding discussions had at the recent strategic update briefings, RC330 was heading down the path of being a wearable injectable not an oral formulation. Take this as hearsay and not official company direction.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.